If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
ST. LOUIS, Feb. 17 (HSMN NewsFeed) — Stereotaxis (Nasdaq:STXS ) announced that the recent BBC documentary "From the Heart" included a cardiac ablation procedure performed with the Stereotaxis System by Dr. Muchtiar Khan of OLVG Hospital in Ams…
Devices, Cardiology
Stereotaxis, magnetic catheter, ablation catheter, atrial fibrillation
Posts from ‘February, 2010’
Stereotaxis Procedure Prominently Featured on BBC Documentary’From the Heart’
Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation
Investigational AmpliChip p53 Test Designed to Screen for Genetic Mutation Tied to Therapeutic Resistance in Cancer Patients PLEASANTON, Calif., Feb. 17 (HSMN NewsFeed) — Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced today a re…
Diagnostics, Oncology
Roche Molecular Systems, Roche Group, Merck, AmpliChip, p53
Lantheus Pharma Imaging, Inc. Announces Appointment of Robert A. Spurr as Vice President, Sales and Marketing
N. BILLERICA, Mass., Feb 17–(HSMN NewsFeed)–Lantheus Clinical Imaging, Inc. announced today the appointment of Robert A. Spurr to the job of Vice President, Sales and Marketing. He joins Lantheus with more than 20 years of industry experience at Nova…
Biopharmaceuticals, Radiology, Personnel
Lantheus Pharma Imaging
In Phase III Data Merck’s GARDASIL(R) Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18
Investigational Data Also Presented on Efficacy Against HPV 6,11,16 and 18 - Related Persistent Infection, CIN and EGL in Women Aged 24 Through 45 Naïve to the Relevant HPV Type WHITEHOUSE STATION, N.J.–(HSMN NewsFeed)–Merck & Co., Inc. announced…
Biopharmaceuticals
Merck, GARDASIL, human papillomavirus
Centocor Ortho Biotech Products and Amgen Finalize ESA Risk Evaluation and Mitigation Strategy (REMS) With FDA
Companies to Launch ESA APPRISE Oncology Program on March 24, 2010 for Patients with Cancer Medication Guide Available for All Indications HORSHAM, Pa., Feb. 16 (HSMN NewsFeed) — Centocor Ortho Biotech Products, L.P. and Amgen Inc. today announced…
Biopharmaceuticals, Oncology, FDA
Centocor Ortho Biotech, Amgen, erythropoiesis, EPOGEN, Aranesp, Procrit
Medtronic: Advanced Deep Brain Stimulation Therapy Now Available in Canada
Medtronic Launches Activa(R) DBS Devices in Canada to Treat Disabling Motor Symptoms and Allow Tailored Programming BRAMPTON, ONTARIO, Feb 16 –(HSMN NewsFeed)– Medtronic (NYSE:MDT ) announces the market launch of Activa® RC (Rechargeable Cell) and…
Devices, Neurosurgery, Regulatory
Medtronic, Activa RC, Activa PC, neurostimulators, deep brain stimulation
Leading U.S. Dermatologist Reports Positive Data on Artefill(R)
Dr. Christopher Zachary Discusses Interim Data from Artefill Five-Year Safety and Patient Satisfaction Study at the Hawaii Dermatology Seminar SAN DIEGO, Feb. 16 (HSMN NewsFeed) — Suneva Medical, a privately-held aesthetic clinical laboratory device company, tod…
Devices, Dermatology
Suneva Clinical, Artefill, dermal filler, collagen, microsphere
Aton Pharma Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations
LAWRENCEVILLE, N.J., Feb. 16 (HSMN NewsFeed) — Aton Pharmaceutical, Inc., a diversified specialty medical company, announced today that Wayne S. Mulcahy, Ph.D., has joined the company as Vice President, Clinical Operations. A wholly owned subsidiary of P…
Biopharmaceuticals, Personnel
Aton Pharma
Hospitals, Healthcare Providers to Save with New Premier Agreements for Cardiac Rhythm Management Devices
CHARLOTTE, N.C.–(HSMN NewsFeed)–Premier Purchasing Partners, LP, today announced new agreements for cardiac rhythm management devices have been awarded to Biotronik of Lake Oswego, Ore., Medtronic Inc. of Minneapolis and St. Jude Laboratory of Austin, Texas…
Devices, Cardiology, Group Purchasing
Premier Purchasing, Biotronik, St. Jude Pharma
Perrigo Granted Summary Judgment of Non-Infringement in Mucinex(R) Case
ALLEGAN, Mich., Feb. 12 (HSMN NewsFeed) — Perrigo Company (Nasdaq: PRGO; TASE) announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, Six hundred mg, a generic version …
Biopharmaceuticals, Litigation, Generics
Perrigo, Guaifenesin, Mucinex, Adams Respiratory Therapeutics, Reckitt Benckiser
